← National Healthcare Properties, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | ($20.9m) | ($42.5m) | ($52.8m) | ($88.1m) | — | — | — | — | — | — | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | ($78.8m) | ($92.9m) | ($93.3m) | ($86.1m) | ($203.5m) | ($71.1m) | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($21.0m) | ($42.7m) | ($53.0m) | ($88.3m) | ($75.5m) | ($85.4m) | ($79.6m) | ($72.4m) | ($190.3m) | ($57.7m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | ($96k) | ($164k) | ($216k) | ($393k) | $303k | ($260k) | ($135k) | ($82k) | ($567k) | ($64k) | |
| Depreciation, Depletion and Amortization | $98.9m | $77.6m | $83.2m | $81.0m | $81.1m | $79.9m | $82.1m | $82.9m | $84.1m | $78.3m | |
| Amortization of Debt Issuance Costs | $4.5m | $6.2m | $8.6m | $9.2m | $4.1m | $4.4m | $4.9m | $6.7m | $3.4m | — | |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | — | — | — | $6.8m | $3.5m | $4.8m | |
| Deferred Income Tax Expense (Benefit) | $327k | ($1.5m) | ($428k) | $223k | $4.6m | $0 | $0 | $0 | $0 | $0 | |
| Share-based Payment Arrangement, Noncash Expense | $160k | $470k | $1.2m | $1.3m | $1.3m | $1.3m | $1.2m | $919k | $613k | $3.8m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | — | — | $612k | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | $0 | $0 | $392k | $257k | |
| Income Tax Expense (Benefit) | ($2.1m) | $647k | $197k | $399k | $4.1m | $203k | $201k | $303k | $262k | $161k | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $69.4m | $61.3m | |
| Operating Lease, Expense | — | — | — | $234.2m | $243.5m | $205.8m | $213.4m | $217.8m | $221.1m | $218.9m | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | — | $272k | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $8.2m | $6.2m | $7.7m | $3.8m | $2.4m | $761k | $1.5m | $1.0m | $794k | $3.4m | |
| Payments of Financing Costs | $3.0m | $14.4m | $3.4m | $19.5m | $2.2m | $1.5m | $1.7m | $8.7m | $0 | $6.2m | |
| Gain (Loss) on Investments | $56k | $0 | $0 | — | — | — | $125k | $322k | — | — | |
| General and Administrative Expense | $12.1m | $15.7m | $17.3m | $20.5m | $21.6m | $16.8m | $17.3m | $18.9m | $22.7m | $24.2m | |
| Nonoperating Income (Expense) | ($18.4m) | ($29.4m) | ($49.6m) | ($56.1m) | ($51.6m) | ($47.8m) | ($47.9m) | ($67.3m) | ($66.5m) | ($60.8m) | |
| Operating Expenses | $307.2m | $323.8m | $365.5m | $415.5m | $406.7m | $370.4m | $367.3m | $350.3m | $486.6m | $366.8m | |
| Unrealized Gain (Loss) on Investments | $6k | $0 | $0 | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $79.4m | $64.0m | $54.2m | $47.4m | $41.8m | $38.9m | $28.3m | $21.6m | ($79.8m) | $7.0m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $7.5m | $8.3m | $12.9m | $16.7m | $21.9m | $19.1m | $28.0m | $22.4m | $21.9m | $28.7m | |
| Gain (Loss) on Sale of Investments | $56k | $0 | $0 | $0 | — | — | $125k | $322k | — | — | |
| Gains (Losses) on Sales of Investment Real Estate | $1.3m | $438k | ($70k) | $8.8m | $5.2m | $3.6m | ($125k) | ($322k) | $9.3m | $27.8m | |
| Net Cash Provided by (Used in) Investing Activities | ($19.1m) | ($194.4m) | ($115.1m) | ($46.2m) | ($82.5m) | ($47.9m) | ($41.8m) | ($62.8m) | $64.0m | $69.8m | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | $0 | $0 | $2.3b | — | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | $12.2m | $33.6m | $14.2m | $21.1m | $10.5m | $0 | $0 | — | — | — | |
| Payments of Ordinary Dividends, Common Stock | $75.4m | $76.7m | $55.3m | $51.4m | $31.4m | $0 | $0 | $91.2m | $23.7m | $0 | |
| Proceeds from Noncontrolling Interests | $0 | $472k | $0 | $0 | — | — | — | $284k | $0 | $0 | |
| Dividends Payable | $12.9m | $11.2m | $6.6m | $6.9m | $742k | $3.4m | $3.5m | $3.5m | $3.5m | $3.3m | |
| Net Cash Provided by (Used in) Financing Activities | ($55.6m) | $199.8m | $49.7m | $19.1m | $19.4m | $4.1m | $4.6m | $56.0m | ($1.3m) | ($42.4m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $4.1m | $69.4m | ($11.2m) | $20.2m | ($21.3m) | ($5.0m) | ($8.8m) | $14.8m | ($17.2m) | $34.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $4.1m | $102.6m | $91.4m | $111.6m | $90.3m | $85.4m | $76.5m | $91.3m | $74.1m | $108.5m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $18.5m | $26.1m | $43.3m | $47.6m | $47.9m | $42.8m | $45.0m | $63.7m | $61.0m | $54.0m | |
| Income Taxes Paid, Net | $339k | $28k | $407k | $447k | $315k | $311k | $566k | $454k | $416k | ($10k) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.